![Patrick Malloy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Patrick Malloy is currently the Senior Vice President-Investor Relations at Abivax SA since 2023.
Prior to this, he worked as the VP-Investor Relations & Corporate Communications at Arena Pharmaceuticals, Inc. and as the SVP-Investor Relations & Strategic Communications at VectivBio Holding AG.
Actieve functies van Patrick Malloy
| Bedrijven | Functie | Begin |
|---|---|---|
| ABIVAX | Investor Relations Contact | 23-08-2023 |
Eerdere bekende functies van Patrick Malloy
| Bedrijven | Functie | Einde |
|---|---|---|
| VECTIVBIO HOLDING AG | Investor Relations Contact | - |
| ARENA PHARMACEUTICALS | Public Communications Contact | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
5
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
VectivBio Holding AG
 VectivBio Holding AG Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for rare diseases | Health Technology |
